Search

Author/Creator Green, Justin A

1. 1953. Immune responses, viral shedding, and COVID-19 symptom burden from breakthrough SARS-CoV-2 infection in a 2:1 randomized, double-blind, placebo-controlled Phase 3 study of AZD1222 (ChAdOx1 nCoV-19) vaccination. (15th December 2022)

Authors:
Sobieszczyk, Magdalena E; Falsey, Ann R; Luetkemeyer, Anne F; Paulsen, Grant C; Riddler, Sharon A; Robb, Merlin L; Rolle, Charlotte-Paige M; Sha, Beverly E; Tong, Tina; Ahani, Bahar; Aksyuk, Anastasia A; Bansal, Himanshu; Green, Justin A; Jepson, Brett; Maaske, Jill; Shoemaker, Kathryn; Sproule, ...
Journal:
Open forum infectious diseases
Issue:
Volume 9:(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial. (February 2022)

Authors:
Vélez, Iván D; Hien, Tran T; Green, Justin A; Martin, Ana; Sharma, Hema; Rousell, Victoria M; Breton, John J; Ernest, Terry B; Rolfe, Katie; Taylor, Maxine; Mohamed, Khadeeja; Jones, Siôn W; Chau, Nguyen Hoang; Hoa, Nhu Thi; Duparc, Stephan; Tan, Lionel K; Goyal, Navin
Journal:
Lancet
Issue:
Volume 6:Number 2(2022)
Page Start:
86
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search